Edinburgh Research Explorer

CMV enhancer-promoter is preferentially active in exocrine cells in vivo

Research output: Contribution to journalArticle

Standard

CMV enhancer-promoter is preferentially active in exocrine cells in vivo. / Vasey, D B; Lillico, S G; Sang, H M; King, T J; Whitelaw, C B A.

In: Transgenic Research, Vol. 18, No. 2, 04.2009, p. 309-14.

Research output: Contribution to journalArticle

Harvard

Vasey, DB, Lillico, SG, Sang, HM, King, TJ & Whitelaw, CBA 2009, 'CMV enhancer-promoter is preferentially active in exocrine cells in vivo', Transgenic Research, vol. 18, no. 2, pp. 309-14. https://doi.org/10.1007/s11248-008-9235-y

APA

Vasey, D. B., Lillico, S. G., Sang, H. M., King, T. J., & Whitelaw, C. B. A. (2009). CMV enhancer-promoter is preferentially active in exocrine cells in vivo. Transgenic Research, 18(2), 309-14. https://doi.org/10.1007/s11248-008-9235-y

Vancouver

Vasey DB, Lillico SG, Sang HM, King TJ, Whitelaw CBA. CMV enhancer-promoter is preferentially active in exocrine cells in vivo. Transgenic Research. 2009 Apr;18(2):309-14. https://doi.org/10.1007/s11248-008-9235-y

Author

Vasey, D B ; Lillico, S G ; Sang, H M ; King, T J ; Whitelaw, C B A. / CMV enhancer-promoter is preferentially active in exocrine cells in vivo. In: Transgenic Research. 2009 ; Vol. 18, No. 2. pp. 309-14.